Recent Finacing
Recent Raise
Methylation Sciences is a clinical-stage Vancouver pharmaceutical developing Strada (MSI-195), an oral S-adenosyl methionine–based adjunctive therapy for major depressive disorder, advancing into confirmatory Phase 2B trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor